• James Barder

    James Barder

    Chief Executive


    Current roles

    James Barder is the Group’s Chief Executive. He assists the Remuneration Committee and the Nominations Committee (but is not a member of and does not vote on either). He has overall responsibility for all activities of the Group, is a principal contact for shareholder and investor relations and leads commercial negotiations. 

    Past roles

    Managing Director of Aon Capital Markets Limited and Non-Executive Director of Lorega Limited. James predominantly worked in the field of insurance and finance including firms he founded. 

    Brings to the Board

    Over 25 years of experience in setting up, managing and running companies.


  • Ken James

    Ken James

    Executive Director and Head of R&D


    Current roles

    Ken James is the Head of R&D. He oversees the development, regulatory and manufacturing strategies for the Group’s existing pipeline and the evaluation of early stage pipeline opportunities. He is also an Executive Director.

    Past roles

    Senior Vice President of Research and Development for GlaxoSmithKline Worldwide Consumer Healthcare, having worked in the UK and the United States.

    Brings to the Board

    Over 40 years’ experience in the research, development and commercialisation of consumer healthcare products.


  • Angela Hildreth

    Angela Hildreth

    Finance Director and Chief Operating Officer


    Current roles

    Angela joined the company in February 2018. She leads the Group’s finance, HR and IT functions, inputs into commercial and financial strategy, leads the Group's compliance procedures and is a principal contact for shareholder and investor relations matters. Angela is also the Company Secretary.

    Past roles

    Senior financial roles in a diverse range of industries, including 7 years as UK Finance Director at Shield Therapeutics plc.

    Brings to the Board

    Strategic and operational financial experience of developing and commercialising pharmaceutical products.


  • John Clarke

    John Clarke

    Non-Executive Chairman


    Current roles

    John Clarke is the Chairman of Futura Medical plc. He chairs the Nominations Committee and is a member of the Audit Committee and the Remuneration Committee. He is also the Non-Executive Chairman of Science in Sport plc, Kind Consumer Holdings Limited and is a senior adviser to Helios Investment Partners LLP.

    Past roles

    Retired from GSK as President of GSK Consumer Healthcare. Under his leadership, GSK Consumer Healthcare became one of the fastest-growing companies in its industry. Non-executive Chairman of Quantum Pharma Plc. 

    Brings to the Board

    Extensive experience of the healthcare sector, having worked at a senior level at GSK for more than 35 years.


  • Jonathan Freeman

    Jonathan Freeman, BA (Hons), MBA

    Senior Independent Non-Executive Director


    Current roles

    Jonathan Freeman is a Senior Independent Non-Executive Director. He chairs the Audit Committee and the Remuneration Committee and is also a member of the Nominations Committee. He is also a Non-Executive Director of Braveheart Investment Group plc and of Kingswood Holdings Limited.

    Past roles

    Director of Beeson Gregory, Chief Executive Officer of Syndicate Asset Management plc and a Director of Hume Capital Securities plc and a Director of Bould Opportunities plc.

    Brings to the Board

    Over 25 years of experience in the financial services sector, guidance on City regulatory matters, corporate finance and investor relations.